Myeloid leukemia cells with a B7-2+ subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands

European Journal of Immunology

Volumn 43, Issue 3, 2013, Pages 747-757

  Dolen, Yusuf ^a   Esendagli, Gunes ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

B7 H1; Cancer; Costimulation; ICOS; Immune escape; PD 1

Indexed keywords

CD86 ANTIGEN; INDUCIBLE T CELL COSTIMULATOR LIGAND;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

ANTIGENS, CD274; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; GENE EXPRESSION; HL-60 CELLS; HUMANS; IMMUNE TOLERANCE; LEUKEMIA, MYELOID; LIGANDS; LYMPHOCYTE ACTIVATION; PROGRAMMED CELL DEATH 1 RECEPTOR; PROTEIN KINASE C; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84874982295     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242814     Document Type: Article

References (36)

1. Smith-Garvin, J. E., Koretzky, G. A. and Jordan, M. S., T cell activation. Annu. Rev. Immunol. 2009. 27: 591-619.
2. Collins, M., Ling, V. and Carreno, B. M., The B7 family of immune-regulatory ligands. Genome Biol. 2005. 6: 223-230.
3. Driessens, G., Kline, J. and Gajewski, T. F., Costimulatory and coinhibitory receptors in anti-tumor immunity. Immunol. Rev. 2009. 229: 126-144.
4. Sharpe, A. H., Mechanisms of costimulation. Immunol. Rev. 2009. 229: 5-11.
5. Zang, X. and Allison, J. P., The B7 family and cancer therapy: costimulation and coinhibition. Clin. Cancer Res. 2007. 13: 5271-5279.
6. Graf, M., Reif, S., Hecht, K., Pelka-Fleischer, R., Kroell, T., Pfister, K. and Schmetzer, H., High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML). Ann. Hematol. 2005. 84: 287-297.
7. Hirano, N., Takahashi, T., Takahashi, T., Ohtake, S., Hirashima, K., Emi, N., Saito, K. et al., Expression of costimulatory molecules in human leukemias. Leukemia 1996. 10: 1168-1176.
8. Tamura, H., Dan, K., Tamada, K., Nakamura, K., Shioi, Y., Hyodo, H., Wang, S. D. et al., Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Clin. Cancer Res. 2005. 11: 5708-5717.
9. Maeda, A., Yamamoto, K., Yamashita, K., Asagoe, K., Nohgawa, M., Kita, K., Iwasaki, H. et al., The expression of co-stimulatory molecules and their relationship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7-2-positive leukaemia. Br. J. Hematol. 1998. 102: 1257-1262.
10. Chen, X., Liu, S., Wang, L., Zhang, W., Ji, Y. and Ma, X., Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia. Cancer Biol. Ther. 2008. 7: 624-629.
11. Whiteway, A., Corbett, T., Anderson, R., Macdonald, I. and Prentice, H. G., Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission. Br. J. Hematol. 2003. 120: 442-451.
12. Salih, R. H., Wintterle, S., Krusch, M., Kroner, A., Huang, Y. H., Chen, L. and Wiendl, H., The role of leukemia-derived B7-H1 (PD-L1) in tumor - T-cell interactions in humans. Exp. Hematol. 2006. 34: 888-894.
13. Norde, W. J., Maas, F., Hobo, W., Korman, A., Quigley, M., Kester, M. G. D., Hebeda, K. et al., PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation. Cancer Res. 2011. 71: 5111-5122.
14. Berthon, C., Driss, V., Liu, J., Kuranda, K., Leleu, X., Jouy, N., Hetuin, D. et al., In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunol. Immunother. 2010. 59: 1839-1849.
15. Saudemont, A. and Quesnel, B., In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 2004. 104: 2124-2133.
16. Kaleem, Z., Crawford, E., Pathan, M. H., Jasper, L., Covinsky, M. A., Johnson, L. R. and White, G., Flow cytometric analysis of acute leukemias diagnostic utility and critical analysis of data. Arch. Pathol. Lab. Med. 2003. 127: 42-48.
17. Bain, B. J., Leukemia diagnosis. Blackwell Science, Malden, 1999.
18. Birnie, G., The HL-60 cell line: a model system for studying human myeloid cell differentiation. Br. J. Cancer 1988. 58: 41-45.
19. White, S. L., Belov, L., Barber, N., Hodgkin, P. D. and Christopherson, R. I., Immunophenotypic changes induced on human HL60 leukaemia cells by 1alpha, 25-dihydroxyvitamin D3 and 12-O-tetradecanoyl phorbol-13-acetate. Leuk. Res. 2005. 29: 1141-1151.
20. Dalton, W. T., Jr., Ahearn, M. J., McCredie, K. B., Freireich, E. J., Stass, S. A. and Trujillo, J. M., HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 1988. 71: 242-247.
21. Ford, G. S., Barnhart, B., Shone, S. and Covey, L. R., Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J. Immunol. 1999. 162: 4037-4044.
22. Nunes, J., Klasen, S., Franco, M. D., Lipcey, C., Mawas, C., Bagnasco, M. and Olive, D., Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-specific phospholipase C activity. Biochem. J. 1993. 293: 835-842.
23. Kariv, I., Truneh, A. and Sweet, R. W., Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function. J. Immunol. 1996. 157: 29-38.
24. Botturi, K., Lacoeuille, Y., Thomas, P., Boniface, S., Reynaud-Gaubert, M. and Mangan, A., CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients. Eur. Respir. J. 2008. 31: 1167-1176.
25. + T cell subsets that are differentially depleted during HIV infection. J. Immunol. 2008. 180: 5582-5592.
26. Keir, M. E., Butte, M. J., Freeman, G. J. and Sharpe, A. H., PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008. 26: 677-704.
27. Zitvogel, L., Tesniere, A. and Kroemer, G., Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 2006. 6: 715-727.
28. Buggins, A. G. S., Lea, N., Gaken, J., Darling, D., Farzaneh, F., Mufti, G. J. and Hirst, W. J. R., Effect of costimulation and the microenvironment on antigen presentation by leukemic cells. Blood 1999. 94: 3479-3490.
29. Cignetti, A., Vallario, A., Roato, I., Circosta, P., Allione, B., Casorzo, L., Ghia, P. et al., Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses. J. Immunol. 2004. 173: 2855-2865.
30. Costello, R., Mallet, F., Sainty, D., Maraninchi, D., Gastaut, J. A. and Olive, D., Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Eur. J. Immunol. 1998. 28: 90-103.
31. Kondo, A., Yamashita, T., Tamura, H., Zhao, W., Tsuji, T., Shimizu, M., Shinya, E. et al., Interferon-γ and tumor necrosis factor-α induce an immunoinhibitory molecule, B7-H1, via nuclear factor-κB activation in blasts in myelodysplastic syndromes. Blood 2010. 116: 1124-1131.
32. Bennett, F., Luxenberg, D., Ling, V., Wang, I. M., Marquette, K., Lowe, D., Khan, N. et al., Program Death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 2003. 170: 711-718.
33. Ge, W., Ma, X., Li, X., Wang, Y., Li, C., Meng, H., Liu, X. et al., B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells. Leuk. Res. 2009. 33: 948-957.
34. Vereecque, R., Buffenoir, G., Gonzalez, R., Cambier, N., Hetuin, D., Bauters, F., Fenaux, P. et al., γ-ray irradiation induces B7.1 expression in myeloid leukaemic cells. Br. J. Hematol. 2000. 108: 825-831.
35. Maeda, T., Towatari, M., Kosugi, H. and Saito, H., Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells. Blood 2000. 96: 3847-3856.
36. Vereecque, R., Saudemont, A. and Quesnel, B., Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells. Leukemia 2004. 18: 1223-1230.